Brief: Simulations Plus- U.S. FDA Renews Licenses Of Dilisym Software
20/04/2021 13:49
April 20 (Reuters) - Simulations Plus Inc SLP.O :
* SIMULATIONS PLUS INC - U.S. FDA RENEWS LICENSES OF DILISYM
SOFTWARE
* U.S. FDA RENEWS LICENSES OF DILISYM SOFTWARE
Source text for Eikon: ID:nBw4x2JQqa
Further company coverage: SLP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simulations Plus
See all newsBrief: Simulations Plus Altaris To Pay $26 Million Termination Fee To Co If Merger Agreement Terminated
NASDAQ RESUMED AT 09:55 AM
Brief: Simulations Plus To Be Acquired By Altaris For Approximately $375 Million
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:55 AM
Simulations Plus Q2 results beat expectations but lowers annual profit forecast on tax rate jump